Ophthalmology · New York, NY
NPI
1912987967
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
310 E 14th St, Suite #304
New York, NY, 10003
Phone (212) 477-7540
Groups this clinician bills Medicare through
Medicare paid, 2024
$521K
7,597 services
Medicare patients, 2024
1,206
Average age 78
Drug cost, 2024
$822K
4,422 prescriptions
Company payments, 2025
$201
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Celso Tello was code 92083 (vision, hearing, and speech services), 1,713 times for 973 patients. In total Celso Tello billed 7,597 services in 35 codes, and Medicare paid $521K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-06-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92083 Vision, Hearing, and Speech Services | Office | 1,713 | 973 | $51.92 | $89K |
| 92012 Ophthalmological E&M | Office | 1,367 | 923 | $70.74 | $97K |
| 92020 Ophthalmological E&M | Office | 874 | 813 | $22.06 | $19K |
| 92014 Ophthalmological E&M | Office | 791 | 738 | $99.92 | $79K |
| 92250 Angiography | Office | 778 | 759 | $30.35 | $24K |
| 92133 Computerized Ophthalmic Imaging | Office | 769 | 757 | $27.92 | $21K |
| 76513 Ultrasound - Nonspecific | Office | 249 | 202 | $125.45 | $31K |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 142 | 97 | $176.57 | $25K |
| 92136 Ultrasound - Nonspecific | Office | 125 | 116 | $37.66 | $4,707 |
| 92004 Ophthalmological E&M | Office | 115 | 115 | $104.21 | $12K |
| 76514 Ultrasound - Nonspecific | Office | 112 | 112 | $8.18 | $916 |
| 66761 Fluid Flow and Drainage of Eye (Any Method) | Office | 110 | 59 | $257.17 | $28K |
| 92134 Computerized Ophthalmic Imaging | Office | 102 | 95 | $33.97 | $3,465 |
| 66984 Cataract Surgery | Facility | 65 | 47 | $345.81 | $22K |
| 92002 Ophthalmological E&M | Office | 52 | 52 | $54.82 | $2,851 |
By year: 2022 $385K for 5,528 services; 2023 $416K for 6,035 services; 2024 $521K for 7,597 services.
Medicare prescription drug claims, 2024
In 2024, the drug Celso Tello prescribed most often to Medicare patients was Latanoprost, with 876 prescriptions and refills. In total Celso Tello wrote 4,422 Medicare prescriptions that cost $822K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 876 | 2,215 | 306 | $12K |
| Timolol Maleate Generic | 437 | 1,098 | 150 | $34K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 352 | 853 | 116 | $8,876 |
| Lumigan Bimatoprost | 340 | 766 | 113 | $195K |
| Brimonidine Tartrate Generic | 274 | 701 | 100 | $9,718 |
| Prednisolone Acetate Generic | 266 | 413 | 184 | $14K |
| Simbrinza Brinzolamide/Brimonidine Tart | 237 | 431 | 66 | $87K |
| Travoprost Generic | 211 | 477 | 72 | $39K |
| Dorzolamide Hcl Generic | 172 | 413 | 66 | $4,201 |
| Brinzolamide Generic | 158 | 376 | 56 | $31K |
| Combigan Brimonidine Tartrate/Timolol | 121 | 230 | 34 | $60K |
| Dorzolamide-Timolol Dorzolamide/Timolol/Pf | 104 | 206 | 32 | $20K |
| Alphagan P Brimonidine Tartrate | 91 | 204 | 34 | $47K |
| Ketorolac Tromethamine Generic | 90 | 105 | 61 | $1,920 |
| Ofloxacin Generic | 80 | 105 | 62 | $1,578 |
Brand drugs: 1,940 claims; generic drugs: 2,482 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Celso Tello $201 ($201 in general payments such as food, travel and fees) from 1 company. The largest payer was Glaukos Corporation with $201.
| Company | Payments | Amount |
|---|---|---|
| Glaukos Corporation GKOS | 1 | $201 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.